INDICATION
Plavix® (clopidogrel bisulfate) is a prescription medicine for patients who have had recent heart attack, recent stroke, or have been diagnosed with P.A.D. known as poor circulation in the legs.

You and your doctor chose
Plavix® (clopidogrel bisulfate) to help reduce
the risk of a future heart attack or stroke.

Plavix® (clopidogrel bisulfate) was FDA approved in 1997. Doctors have written
Plavix® (clopidogrel bisulfate) prescriptions to over 115 million people.††
Plavix® (clopidogrel bisulfate) is one of the most researched prescription antiplatelet medicines.††

Click here to view animation

PLAVIX helps keep platelets in the blood from sticking together and
forming clots—the direct cause of most heart attacks and strokes.

View Video

If you and your doctor choose
to continue with brand name PLAVIX
after lower-cost generic clopidogrel
bisulfate becomes available on May 17th...

IMPORTANT SAFETY INFORMATION
Certain genetic factors and some medicines such as Prilosec or Nexium reduce the effect of PLAVIX leaving you at greater risk for heart attack and stroke. Your doctor may use genetic tests to determine treatment. Don’t stop taking PLAVIX without talking to your doctor as your risk of heart attack or stroke may increase. People with stomach ulcers or conditions that cause bleeding should not use PLAVIX. Taking PLAVIX alone or with some other medicines, including aspirin, may increase bleeding risk which can potentially be life-threatening. So tell your doctor when planning surgery. Tell your doctor all medicines you take, including aspirin, especially if you’ve had a stroke. If fever, unexplained weakness or confusion develops, tell your doctor promptly. These may be signs of TTP, a rare but potentially life-threatening condition, reported sometimes less than 2 weeks after starting PLAVIX.

INDICATIONS
Plavix® (clopidogrel bisulfate) is a prescription only medicine that helps keep blood platelets from sticking together and forming clots.

PLAVIX is for patients who have:
• had a recent heart attack
• had a recent stroke
• poor circulation in the legs (Peripheral Artery Disease)

PLAVIX in combination with aspirin is for patients hospitalized with:
• heart-related chest pain
• heart attack
Doctors may refer to these conditions as ACS (Acute Coronary Syndrome).

Always talk to your doctor before taking aspirin or other medicines with PLAVIX, especially if you've had a stroke.

 

Click here for US Full Prescribing Information Including BOXED WARNING and Medication Guide for PLAVIX

Remember, your doctor is the single best source of information regarding your health. Please consult your doctor if you have any questions about your health or your medicine.

Learn how PLAVIX helps

ELIGIBILITY REQUIREMENTS AND TERMS OF USE
Eligibility: Patients are not eligible if their prescriptions are paid in part or in full by any state or federally funded programs, including but not
limited to Medicare or Medicaid, Medigap, VA, DOD or TRICARE. Offer not valid in Massachusetts or where prohibited by law, taxed or restricted. Offer good only in the USA and Puerto Rico.

Terms of Use: Eligible (commercially-insured or cash-paying) patients whose out-of-pocket expense for 30 Plavix(clopidogrel bisulfate) tablets is more than $37 can receive up to $176.50 in savings. Savings not applicable to monthly out-of-pocket expense of $37 or less. This card is valid toward out-of-pocket expense only, excluding applicable taxes. This offer is only valid when your card is activated and accompanied by a prescription from your doctor for brand name PLAVIX. Void where prohibited by law. Offer valid between 5/17/2012 and 12/31/2012. Card expires on 12/31/2012. The Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership retains the right to rescind, revoke or amend this offer at any time, without notice. The PLAVIX Choice Card is not an insurance program. If you have prescription drug insurance, your acceptance of this offer confirms that this is consistent with your insurance and that you will report the value received as may be required by your insurance provider.



Please note:

You are about to leave a Bristol-Myers Squibb/
Sanofi Pharmaceuticals Partnership site.

The Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership does not review the information on this Web site and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the Web site and/or database producer.

The Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership makes no representation as to the accuracy or any other aspect of the information contained on such Web site and/or database, nor does Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership necessarily endorse such Web site and/or database.

Cancelgo

Health-care Professional

You are about to enter a site intended solely for the use of health-care professionals. Please certify that you are a health-care professional by clicking the button below marked "I Agree," or simply click the button marked "I Do Not Agree" to return to the previous page.

I AgreeI Do Not Agree

Please note:

You are about to leave the Bristol-Myers Squibb/
Sanofi Pharmaceuticals PLAVIX.com site.

You are being redirected to a Bristol-Myers Squibb corporate site. You are linking to any other off-site pages or other sites at your own risk.

Cancelgo

Share with a friend

Close

*Required Field

*

*

Subject: Information from plavix.com sent to you by a friend

*

Your friend asked us to send you a link to the following article at www.PLAVIX.com

Click the link below to read the full article:
PLAVIX(R) (clopidogrel bisulfate): May Help Protect Against Blood Clot Formation
www.PLAVIX.com

This article was bought to you by www.PLAVIX.com

*

Share with a friend

Close
Thank you. The requested page has been sent to the email address you provided. Return to the page you were viewing